DNA Repository Substudy in association with rhuMAb BETA7 (PRO145223) Study ABS4986g [SUBSTUDY OF 700197675]

Trial Profile

DNA Repository Substudy in association with rhuMAb BETA7 (PRO145223) Study ABS4986g [SUBSTUDY OF 700197675]

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Etrolizumab (Primary)
  • Indications Ulcerative colitis
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 23 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top